Treatment related changes in antifibrinolytic activity in patients with polycythemia vera

Author： Sonmez Mehmet Saglam Fatma Karahan S. Caner Erkut Nergiz Mentese Ahmet Sonmez Bircan Ucar Fahri Topbas Murat Ovali Ercument

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.15, Iss.6, 2010-12, pp. : 391-396

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polycythemia vera-related MDS in a dog

By Nassiri Seyed

Comparative Clinical Pathology, Vol. 19, Iss. 6, 2010-12 ,pp. : 627-630

Springer Publishing Company

Access to resources Recommend Favorite

Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis

By Silver Richard T Kiladjian Jean-Jacques Hasselbalch Hans Carl

Expert Review of Hematology, Vol. 6, Iss. 1, 2013-02 ,pp. : 49-58

Informa Healthcare

Access to resources Recommend Favorite

STAT3 is constitutively active in some patients with Polycythemia rubra vera

By Roder S. Steimle C. Meinhardt G. Pahl H.L.

Experimental Hematology, Vol. 29, Iss. 6, 2001-06 ,pp. : 694-702

Elsevier

Access to resources Recommend Favorite

Analysis of Hemochromatosis Gene Mutations in 52 Consecutive Patients with Polycythemia Vera

By Franchini Massimo de Matteis Giovanna Federici Francesca Solero Pietro Veneri Dino

Hematology, Vol. 9, Iss. 5-6, 2004-10 ,pp. : 413-414

Maney Publishing

Access to resources Recommend Favorite

Thrombotic complications of polycythemia vera

By Varma S. Sharma Aman Malhotra Pankaj Kumari S. Jain S. Varma N.

Hematology, Vol. 13, Iss. 6, 2008-12 ,pp. : 319-323

Maney Publishing

Access to resources Recommend Favorite